STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System ...
Investigators in South Korea identified 84 older individuals with unilateral type 3 macular neovascularization at study entry that progressed to either GA or nAMD over the study period. During an ...
Atrophy Advisor aids in managing GA in AMD by integrating progression and lifespan estimates to guide treatment decisions. GA ...
Pegcetacoplan was approved by the FDA to treat geographic atrophy (GA), providing a treatment option for patients who previously had none, explained Eleonora Lad, MD, PhD, associate professor of ...
DUBLIN, Aug. 25, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced completion of enrollment in the open-label portion of its ...
WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, announced that Medical Specialists Associated (MSA Dallas), an independent internal medicine practice in Dallas, ...
Patients typically live about 6 to 10 years after MSA symptoms first appear, with few patients surviving more than 15 years [1],[2]. MSA is significantly debilitating and classified as a rare disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback